Are you Dr. Sui?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4525 3rd Ave Se
Suite 200
Lacey, WA 98503Phone+1 360-754-3934Fax+1 360-943-8023
Summary
- Dr. Xingwei Sui, MD is an oncologist in Lacey, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with Providence St. Peter Hospital, Multicare Capital Medical Center, and Providence Centralia Hospital.
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 2003 - 2005
- University of TennesseeResidency, Internal Medicine, 2000 - 2003
- Qingdao University Medical CollegeClass of 1984
Certifications & Licensure
- WA State Medical License 2003 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the P...Kevin C Flanagan, Jon Earls, Jeffrey Hiken, Rachel L Wellinghoff, Michelle M Ponder
Journal for Immunotherapy of Cancer. 2024-11-03 - 3 citationsMultidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.Kevin C Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L Wellinghoff
Journal of Cancer Research and Clinical Oncology. 2023-11-01 - 15 citationsPhase II Study of Taselisib in-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.Ian E Krop, Opeyemi A Jegede, Juneko E Grilley-Olson, Josh D Lauring, Edith P Mitchell
JCO Precision Oncology. 2022-02-01